Drug Shortage Report for AURO-CEFIXIME

Last updated on 2023-08-08 History
Report ID 166650
Drug Identification Number 02468689
Brand name AURO-CEFIXIME
Common or Proper name CEFIXIME
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) CEFIXIME
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 50ml
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-12
Estimated end date 2023-09-01
Actual end date 2023-07-31
Shortage status Resolved
Updated date 2023-08-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2023-08-08 French Compare
v22 2023-08-08 English Compare
v21 2023-08-02 French Compare
v20 2023-08-02 English Compare
v19 2023-07-24 French Compare
v18 2023-07-24 English Compare
v17 2023-05-23 French Compare
v16 2023-05-23 English Compare
v15 2023-04-25 French Compare
v14 2023-04-25 English Compare
v13 2023-03-16 French Compare
v12 2023-03-16 English Compare
v11 2023-02-01 French Compare
v10 2023-02-01 English Compare
v9 2023-01-16 French Compare
v8 2023-01-16 English Compare
v7 2022-12-19 French Compare
v6 2022-12-19 English Compare
v5 2022-12-01 French Compare
v4 2022-12-01 English Compare

Showing 1 to 20 of 23